4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-046832
President and CEO gave up 6,210 shares (to pay taxes)
- President and CEO acquired 18,539 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-08-18 | Option exercise | +6,758 | 7,620,225 | D | ||
| Jiang Wenbin President and CEO | 2023-08-18 | Shares withheld for taxes | −2,245 | $8.46 | $18,993 | 7,617,980 | D |
| Jiang Wenbin President and CEO | 2023-08-18 | Option exercise | +11,781 | 7,629,761 | D | ||
| Jiang Wenbin President and CEO | 2023-08-18 | Shares withheld for taxes | −3,965 | $8.46 | $33,544 | 7,625,796 | D |
| Derivatives | |||||||
| Jiang Wenbin President and CEO | 2023-08-18 | Option exercise · Restricted Stock Units | −6,758 | 65,336 | D | ||
| Jiang Wenbin President and CEO | 2023-08-18 | Option exercise · Restricted Stock Units | −11,781 | 168,866 | D | ||
Loading xslF345X05/doc4.xml…